Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Lyme Disease Testing Market Evolve in Terms of Growth and Size by 2029?

There has been substantial growth in the market size for Lyme disease testing in the past few years. The market is projected to increase from $9.77 billion in 2024 to $10.68 billion in 2025, representing a compound annual growth rate (CAGR) of 9.3%. Factors contributing to the growth during the historic period include an escalating demand for early detection of diseases, an increase in the availability of sophisticated diagnostic tools, a surge in tick populations due to changes in climate, an increase in government funding directed towards controlling vector-borne diseases, and an expansion in healthcare infrastructure in both rural areas and endemic regions.

The market size for testing lyme disease is anticipated to witness substantial expansion in the upcoming years, with projections indicating a growth to $15.11 billion by 2029, at a compound annual growth rate (CAGR) of 9.1%. This predicted growth during the forecasted period can be credited to a surge in travel to regions where the disease is prevalent, increased application of multiplex diagnostic technologies, a growing trend of outdoor recreational activities, a heightened demand for home-testing kits and an escalation in concerns related to co-infections from other tick-borne diseases. Key market trends projected for the forecast period encompass advances in molecular diagnostic techniques, breakthroughs in biomarker research, innovative technology in point-of-care testing devices, progress in lab-on-a-chip (microfluidic) technology, and improvements in immunoassay technologies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25817&type=smp

What factors are expected to fuel Lyme Disease Testing market growth in the coming years?

The lyme disease testing market is anticipated to grow owing to the increasing occurrence of tick-borne diseases. These diseases, spread to humans through bites from ticks, tiny parasites that thrive in grassy, remote, or forested areas, cause a surge in Lyme disease testing. Climate change, exacerbating the geographic spread of ticks, results in increased exposure and infection rates, fueling the demand for tick-borne illness treatments. Tick-borne illnesses, being the principal transmission method for Lyme disease, necessitate timely detection and diagnosis to efficiently manage the escalating infection cases. As an illustration, the Centers for Disease Control and Prevention, a federal public health agency based in the US, reported 71,346 cases of tick-borne disease in July 2024, a significant increase from 36,177 cases in 2021. Consequently, the growing incidence of tick-borne diseases is stimulating the expansion of the lyme disease testing market.

What Are The Key Findings From The Segmentation Analysis Of The Lyme Disease Testing Market?

The lyme disease testing market covered in this report is segmented –

1) By Test Type: Serological Tests, Nucleic Acid Tests, Urine Antigen Tests, Other Test Types

2) By Testing Methodology: Enzyme-Linked Immunosorbent Assay (ELISA), Weste Blot, Polymerase Chain Reaction (PCR), Immunofluorescence Assay (IFA), Other Emerging Technologies

3) By Disease Stage: Early Lyme Disease, Disseminated Lyme Disease, Chronic Lyme Disease, Asymptomatic Lyme Disease Detection

4) By Sample Type: Blood, Urine, Cerebrospinal Fluid(CSF), Other Blood Samples

5) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Home Care Settings, Research Institutions, Public Health Organizations

Subsegments:

1) By Serological Tests: Enzyme-Linked Immunosorbent Assay, Western Blot, Immunofluorescence Assay (IFA), Line Immunoassay (LIA)

2) By Nucleic Acid Tests: Polymerase Chain Reaction (PCR), Loop-Mediated Isothermal Amplification (LAMP), Next-Generation Sequencing (NGS)

3) By Urine Antigen Tests: Lateral Flow Assay, Enzyme Immunoassay (EIA), Immunoblot Urine Tests

4) By Other Test Types: Culture-Based Tests, Tick-Borne Co-Infection Panels, Artificial Intelligence-Assisted Diagnostic Tools

Which Trends Are Expected To Shape The Future Of The Lyme Disease Testing Market?

A significant focus for leading companies in the Lyme disease testing market is the progression of innovative diagnostic tools. Their aim is to enhance the precision of tests, streamline the process, and facilitate early detection of the illness. Diagnostic tools encompass various medical devices, kits, or innovative technologies that can detect Lyme disease by identifying specific antibodies, antigens, or the genetic presence related to Borrelia burgdorferi bacteria. To illustrate, EpitogenX Ltd, a biotech company based in the UK, unveiled a state-of-the-art Lyme Disease Diagnostic Kit in August 2024. Developed using their unique EpitoGen platform, this ELISA-based assay includes approximately 120 unique Borrelia epitopes, ensuring high accuracy and sensitivity. It is specifically designed for research use (RUO) and offers early, strain-specific detection. Furthermore, it can be tailored to suit a variety of lab applications. With its intended use for research and diagnostic laboratories, it promises to augment detection precision and provide more comprehensive understanding of Lyme disease.

What Are The Most Active Companies In The Lyme Disease Testing Market Today?

Major companies operating in the lyme disease testing market are Roche Holding AG, Thermo Fisher Scientific Inc., Labcorp Holdings Inc., Quest Diagnostics Incorporated, Eurofins Scientific, BIOMÉRIEUX, Quidel Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A, Meridian Bioscience, Everlywell, Trinity Biotech, T2 Biosystems, IGeneX, Viramed Biotech AG, Ceres Nanosciences, Galaxy Diagnostics, Novatein Biosciences, Lyme Diagnostics Ltd

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/lyme-disease-testing-global-market-report

Which Regional Markets Are Attracting The Most Investment In Lyme Disease Testing?

North America was the largest region in the lyme disease testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lyme disease testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=25817&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model